Drug Profile
Calcitonin intranasal - West Pharmaceutical Services
Alternative Names: Salcatonin intranasal - West Pharmaceutical ServicesLatest Information Update: 04 Feb 2008
Price :
$50
*
At a glance
- Originator West Pharmaceutical Services Drug Delivery and Clinical Research Centre
- Class
- Mechanism of Action Calcitonin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 11 Nov 2003 Calcitonin intranasal is available for licensing (http://www.westpharma.com)
- 20 Sep 2000 No-Development-Reported for Postmenopausal osteoporosis in United Kingdom (Intranasal)
- 02 Jul 1998 Phase-I clinical trials for Postmenopausal osteoporosis in United Kingdom (Intranasal)